Abstract:The ability to precisely modify human genes has been made possible by the development of tools such as meganucleases, zinc finger nucleases, TALENs, and CRISPR/Cas. These now make it possible to generate targeted deletions, insertions, gene knock outs, and point variants; to modulate gene expression by targeting transcription factors or epigenetic machineries to DNA; or to target and modify RNA. Endogenous repair mechanisms are used to make the modifications required in DNA; they include non-homologous end joining, homology-directed repair, homology-independent targeted integration, microhomology-mediated end joining, base-excision repair, and mismatch repair. Off-target effects can be monitored using in silico prediction and sequencing and minimized using Cas proteins with higher accuracy, such as high-fidelity Cas9, enhanced-specificity Cas9, and hyperaccurate Cas9. Alternatives to Cas9 have been identified, including Cpf1, Cas12a, Cas12b, and smaller Cas9 orthologs such as CjCas9. Delivery of gene-editing components is performed ex vivo using standard techniques or in vivo using AAV, lipid nanoparticles, or cell-penetrating peptides. Clinical development of gene-editing technology is progressing in several fields, including immunotherapy in cancer treatment, antiviral therapy for HIV infection, and treatment of genetic disorders such as β-thalassemia, sickle cell disease, lysosomal storage disorders, and retinal dystrophy. Here we review these technological advances and the challenges to their clinical implementation.

What problem does this paper attempt to address?

This paper aims to explore the latest progress in gene - editing technology and the challenges it faces in clinical applications. Specifically, the paper focuses on the following aspects: 1. **Development of gene - editing tools**: - The paper discusses the development of various gene - editing tools, such as Meganucleases, Zinc Finger Nucleases (ZFNs), Transcription Activator - Like Effector Nucleases (TALENs) and the CRISPR/Cas system. These tools make it possible to perform precise gene modifications in the human genome, including operations such as targeted deletion, insertion, gene knockout and point mutation. - It particularly emphasizes the revolutionary impact of the CRISPR/Cas system, as well as its wide application and improvement in gene editing, such as high - fidelity Cas9 for improving specificity, Cas9 for enhancing specificity and Cas9 with ultra - high precision. 2. **Applications of gene - editing**: - The paper explores the applications of gene - editing technology in various fields, including immunotherapy for cancer treatment, antiviral treatment for HIV infection, treatment of genetic diseases (such as β - thalassemia, sickle cell disease, lysosomal storage disorders and retinal dystrophy). - It also introduces the applications of gene - editing in regulating gene expression, RNA modification, etc., such as inhibiting gene transcription through CRISPRi, changing the epigenetic state through the fusion of dCas9 and epigenetic modifiers. 3. **Challenges of gene - editing**: - The paper analyzes in detail the main challenges faced by gene - editing technology in clinical applications, including safety, effectiveness and delivery methods. - In terms of safety, it focuses on issues such as off - target effects, mutations caused by R - loop formation, the impact of p53 on editing efficiency, and unexpected mutations caused by non - homologous end joining (NHEJ). - In terms of effectiveness, it explores how to improve the efficiency of homologous - directed repair (HDR), and the influence of different cell - cycle stages on HDR and NHEJ. - In terms of delivery methods, it introduces various delivery strategies, such as in vitro delivery, in vivo use of adeno - associated virus (AAV), lipid nanoparticles or cell - penetrating peptides. In conclusion, this paper attempts to comprehensively summarize the latest progress in gene - editing technology and deeply analyze various challenges faced by these technologies in clinical applications, providing guidance for future research and applications.

Sharpening the Molecular Scissors: Advances in Gene-Editing Technology

Current landscape of gene‐editing technology in biomedicine: Applications, advantages, challenges, and perspectives

Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human Disease

Development and application of CRISPR/Cas9 technologies in genomic editing.

Utilization of TALEN and CRISPR/Cas9 Technologies for Gene Targeting and Modification

Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.

Recent Therapeutic Gene Editing Applications to Genetic Disorders

Gene Editing's Sharp Edge: Understanding Zinc Finger Nucleases (ZFN), Transcription Activator-Like Effector Nucleases (TALEN) and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)

New advances in CRISPR/Cas-mediated precise gene-editing techniques

Precision Genome Editing Techniques in Gene Therapy: Current State and Future Prospects

Genome-Editing Technologies: Principles and Applications.

Genome-Editing Technologies: Concept, Pros, and Cons of Various Genome-Editing Techniques and Bioethical Concerns for Clinical Application

Oligonucleotide-directed gene-editing technology: mechanisms and future prospects

Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics

Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing

Gene Editing Technology and Ethical Issues

Scientists sharpen their molecular scissors and expand the gene editing toolbox

CRISPR/Cas9-mediated genome editing: from basic research to gene therapy

Genome-editing Technologies for Gene and Cell Therapy

The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects